These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3081375)

  • 21. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human.
    Hall JE; Bhatta N; Adams JM; Rivier JE; Vale WW; Crowley WF
    J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of pituitary gonadotropins in follicular stimulation and oocyte maturation in the human.
    Jones GS; Garcia JE; Rosenwaks Z
    J Clin Endocrinol Metab; 1984 Jul; 59(1):178-80. PubMed ID: 6427270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gonadotropin-releasing hormone antagonist versus agonist administration in women undergoing controlled ovarian hyperstimulation: cycle performance and in vitro steroidogenesis of granulosa-lutein cells.
    Minaretzis D; Alper MM; Oskowitz SP; Lobel SM; Mortola JF; Pavlou SN
    Am J Obstet Gynecol; 1995 May; 172(5):1518-25. PubMed ID: 7755066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH.
    Ubaldi F; Camus M; Smitz J; Bennink HC; Van Steirteghem A; Devroey P
    Fertil Steril; 1996 Aug; 66(2):275-80. PubMed ID: 8690116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and biophysical indices of follicular development in spontaneous and stimulated ovulatory cycles.
    Fossum GT; Vermesh M; Kletzky OA
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):407-11. PubMed ID: 2106108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibody production in rhesus monkeys following prolonged administration of human chorionic gonadotropin.
    Ottobre JS; Stouffer RL
    Fertil Steril; 1985 Jan; 43(1):122-8. PubMed ID: 3917404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist.
    Younis JS; Matilsky M; Radin O; Ben-Ami M
    Fertil Steril; 2001 Aug; 76(2):294-9. PubMed ID: 11476775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolated hypogonadotropic hypogonadism: induction of ovulation with exogenous gonadotropins.
    Spitz IM; Rosen E; Ben-Aderet N; Polishuk W; Jaffe H; Bercovici B
    Fertil Steril; 1977 May; 28(5):535-40. PubMed ID: 856636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of corpora lutea in monkeys after superovulation with human menopausal gonadotropin or follicle-stimulating hormone.
    Stouffer RL; Hodgen GD; Graves PE; Danforth DR; Eyster KM; Ottobre JS
    J Clin Endocrinol Metab; 1986 May; 62(5):833-9. PubMed ID: 3007556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog.
    Serafini P; Stone B; Kerin J; Batzofin J; Quinn P; Marrs RP
    Fertil Steril; 1988 Jan; 49(1):90-5. PubMed ID: 3121401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular stimulation versus ovulation induction in juvenile primates: importance of gonadotropin-releasing hormone dose.
    Sopelak VM; Collins RL; Hodgen GD
    J Clin Endocrinol Metab; 1986 Mar; 62(3):557-62. PubMed ID: 3080466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of gonadotropin-releasing hormone agonist on androstenedione production and follicular development during controlled ovarian hyperstimulation.
    Akaboshi K; Oda T; Yoshida J; Kohriyama S; Miyazaki T; Yoshimura Y
    J Assist Reprod Genet; 1998 Sep; 15(8):478-84. PubMed ID: 9785195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal changes induced by short-term administration of gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development.
    Loumaye E; Vankrieken L; Depreester S; Psalti I; de Cooman S; Thomas K
    Fertil Steril; 1989 Jan; 51(1):105-11. PubMed ID: 2491990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of follicular growth and production of a normal hormonal milieu in spite of using a constant low dose of luteinizing hormone in women with hypogonadotrophic hypogonadism.
    Shoham Z; Howles CM; Zalel Y; Weissman A; Insler V
    Hum Reprod; 1994 Mar; 9(3):431-6. PubMed ID: 7516348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotrophins.
    Wildt L; Diedrich K; van der Ven H; al Hasani S; Hübner H; Klasen R
    Hum Reprod; 1986 Jan; 1(1):15-9. PubMed ID: 2971082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine changes following pituitary desensitization with LHRH agonist and administration of purified FSH to induce follicular maturation.
    Shaw RW; Ndukwe G; Imoedemhe DA; Bernard A; Burford G; Bentick B
    Br J Obstet Gynaecol; 1987 Jul; 94(7):682-6. PubMed ID: 3113476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro fertilization management and results in stimulated cycles with spontaneous luteinizing hormone discharge.
    Eibschitz I; Belaisch-Allart JC; Frydman R
    Fertil Steril; 1986 Feb; 45(2):231-6. PubMed ID: 3081376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.